|
TRDA Entrada Therapeutics Inc 1689375 |
| Balance Sheet |
|
Current Assets
|
440,039,000 |
|
Assets
|
526,321,000 |
|
Current Liabilities
|
39,482,000 |
|
Liabilities
|
97,643,000 |
|
Equity
|
428,678,000 |
|
Shares Out
|
38,284,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-41,557,000 |
|
Investing Cash Flow
|
-27,798,000 |
| Market Analysis |
Market Cap
|
499,610,252 |
|
Price
|
13.05 |
|
BVPS
|
11.52 |
|
PB
|
0.91 |
|
EPS
|
-3.47 |
|
PS
|
0.63 |
|
FCF
|
-69,355,000 |
|
| Earnings |
|
| Jan |
Feb |
Mar |
|
|
2/27 |
1.76 |
3/13 |
1.46 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view TRDA documents filed with the SEC.
TRDA Filings
Clear
